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Abstract
Rationale Nicotinic receptors have been implicated in
attentional performance. Nicotine can improve attention in
animals and humans, but knowledge about relevant receptor
subtypes is very limited.
Objectives The aim was to examine the role of α7 receptors
in attentional performance of mice and in effects of
nicotine.
Materials and methods Mice with targeted deletion of the
gene coding for the α7 subunit of nicotinic receptors and
wild-type controls were trained on a five-choice serial
reaction time task with food reinforcers presented under
varying parametric conditions. Nicotine was administered
in a range of doses (0.001–1.0 mg/kg sc), including those
reported to enhance attentional performance.
Results Initially the α7
−/− (knockout) mice responded less
accurately and made more anticipatory responses. After
task parameters were altered so that the time allowed for
responding was reduced and anticipatory (impulsive)
responses were punished by a time-out, the pattern of
performance deficits changed; there were increased omis-
sion errors in α7
−/− mice but normal levels of accuracy and
anticipatory responding. Nicotine did not improve any
measure of performance, either with the original training
parameters or after retraining; the largest dose used
(1.0 mg/kg) produced a general impairment of responding
in α7
−/− and wild-type mice.
Conclusions α7 nicotinic receptor knockout mice are
impaired in performance of the 5-CSRTT, suggesting a
possible role for α7 receptors in attentional processing.
However, identification of a protocol for assessing atten-
tion-enhancing effects of nicotine in mice may require
further modifications of test procedures or the use of
different strains of animal.
Keywords Addiction.Schizophrenia.Nicotinicreceptor.
Nicotine.Mice.Knockout.Drugabuse.Cognition.
Behavior.Attention
Introduction
Nicotinic acetylcholine receptors are pentameric cation
channels, so-called because of the actions of nicotine in
binding to these receptors and bringing about channel
opening. Twelve subunits of neuronal nicotinic receptors
have been identified, α2-10 and β2-4. From these subunits
the two most common nicotinic receptors formed in the
brain are the heteromeric α4β2 and the homomeric α7
nicotinic receptors, at approximately 85 and 10% of total
nicotinic receptors, respectively. The α7 nicotinic receptors
are especially highly expressed in the hippocampus where,
as well as mediating cholinergic neurotransmission, their
high Ca
++ permeability (Seguela et al. 1993) engenders the
capacity to modulate glutamatergic and GABAergic neuro-
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Scotland, UKtransmission both pre- and post-synaptically (Berg and
Conroy 2002). This study aims to shed further light on the
role of α7 receptors in behaviour and in the behavioural
effects of nicotine.
Nicotine is the second most commonly abused drug in
the world after alcohol; cigarette smoking, with its well-
established risks of chronic disease, constitutes a great
burden on societies worldwide. Considerable efforts have
been expended in investigating the function of nicotinic
receptors in nicotine addiction and in other neuropsychiatric
conditions, and in mediating the cognitive effects of
nicotine. For example, cigarette smoking is approximately
twice as common in patients with schizophrenia, as it is
within the general population. The α7 nicotinic receptor has
been implicated in the pathogenesis of schizophrenia and
more specifically in the P50 sensory gating deficit
measurable in approximately 90% of schizophrenics, about
50% of their relatives and about 10% of control subjects
(Waldo et al. 1991). The sensory gating deficit in
schizophrenia is thought to reflect an input dysfunction
that allows greater passage of information through the
hippocampus for processing by other brain areas (Freedman
et al. 2002). The density of α7 nicotinic receptors in
hippocampus and cingulate cortex from schizophrenics is
considerably reduced (Freedman et al. 1995; Marutle et al.
2001). It might, therefore, be expected that performance of
tasks requiring sustained attention would require α7
nicotinic receptors.
Attempts to investigate the functional role of α7
nicotinic receptors at the behavioural level have most often
involved the use of selective agonists and antagonists to
these receptors. Another avenue of research that has
recently become possible uses genetically modified mice
with specific deletions of genes for neuronal nicotinic
receptors. Mice with targeted deletion of the gene for the
α7 nicotinic receptor lack α-bungarotoxin binding sites in
the hippocampus and fast, rapidly desensitizing nicotinic
currents in hippocampal neurons (Orr-Urtreger et al. 1997).
Viability and brain morphology appear normal in these
mice; of special interest is the lack of any impairment of
sensorimotor gating as measured with both auditory and
tactile stimuli in the prepulse inhibition paradigm (Paylor
et al. 1998). This result is consistent with the lack of
improvement in prepulse inhibition with nicotinic α7
agonists (Olivier et al. 2001; Schreiber et al. 2002),
although such agonists are able to improve auditory gating
in animal models of sensory gating deficit (O’Neill et al.
2003).
In other behavioural studies, α7
−/− mice have not proved
to be considerably different in behaviour from wild-type
littermates (Paylor et al. 1998). In locomotion, α7
−/− mice
had a tendency towards less horizontal and vertical activity
and spent significantly more time in the centre of the open
field than the wild-type mice, but in the light–dark test of
anxiety there were no significant differences between the
two groups (Paylor et al. 1998). In the delayed matching-to-
place task in the Morris water maze, α7
−/− mice were
slightly impaired in comparison with wild-types, as shown
by a longer time to find the hidden platform (Fernandes
et al. 2005). Nicotine-induced locomotor depression, hypo-
thermia, seizures, drug discrimination and tolerance were
unchanged in α7
−/− mice (Franceschini et al. 2002; Tritto
et al. 2004; Stolerman et al. 2004; Naylor et al. 2005).
However, the α7
−/− mice were less sensitive to impairments
in contextual learning brought about by ethanol (Wehner
et al. 2004).
The series of experiments presented in this paper use the
five-choice serial reaction time task (5-CSRTT), a com-
monly used model of attentional performance that is
considered analogous to the continuous performance test
used in human research. The test requires responses to
visual stimuli presented in one of five locations in one wall
of an operant conditioning chamber. In a previous study
Young et al. (2004) found that α7
−/− mice took longer to
acquire the task than wild-type C57 Bl/6J mice and made
more omission errors, but they were not different with
respect to accuracy or the latencies of correct responses.
Young et al. (2004) also reported significant improvements
in accuracy and reductions in omission errors at several
doses of nicotine in C57 Bl/6J mice, including a reduction
in the latency of correct responses with a 0.3-mg/kg dose of
nicotine. In this paper, the first published report of nicotine
improving the performance of mice in the 5-CSRTT and the
effects seen were not dose-related, but the findings were
important and need replication and investigation under a
wider range of conditions.
Several studies have reported that nicotine enhances the
attentional performance of rats in the 5-CSRTT (Hahn and
Stolerman 2002; Hahn et al. 2002, 2003a), although the use
of selective nicotinic agonists and antagonists has provided
no evidence for involvement of the α7 receptor. The
relatively specific α7 agonist AR-R17779 had no effect
upon task performance in an experimental procedure in
which administration of nicotine, epibatidine and isoareco-
lone all improved performance (Hahn et al. 2003a). These
agonists all have much higher relative affinities than AR-
R17779 for heteromeric nicotinic receptors. The α4β2
nicotinic agonist SIB1765F has also been shown to
improve 5-CSRTT performance in rats (Grottick and
Higgins 2000). The α7 antagonist methyllycaconitine did
not block the effects of nicotine on response latency and
anticipatory responding, whereas dihydro-β-erythroidine,
an antagonist at heteromeric receptors, did block the effect
of nicotine on these measures (Blondel et al. 2000; Grottick
and Higgins 2000). However, the α7 agonist GTS-21 has
been reported to improve performance in various tests of
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given in repeated doses (Kitagawa et al. 2003) and in a test
of memory in monkeys 24 h after administration (Briggs
et al. 1997). The small number of drugs investigated and
their limited selectivity indicates a need for investigations
on the role of α7r e c e p t o r si na t t e n t i o nb ya n o t h e r
approach, such as the α7
−/− mouse.
The aims of the present study were, therefore, to
investigate the attentional performance of α7
−/− mice using
the 5-CSRTT and to determine whether the gene deletion
influenced any effects of nicotine on performance. If the α7
nicotinic receptor is important in attentional mechanisms
then it should be possible to confirm the attentional deficits
reported by Young et al. (2004)i nα7
−/− mice. If nicotine
improves attention, at least in part, through these receptors
then it should also be possible to show that nicotine-
induced attentional enhancement is diminished in such
animals. The procedures used in the initial stages of
training were based on those of Patel et al. (2006) because
they were close to those used in studies of rats where
nicotine improved performance (Hahn et al. 2002; Hahn
and Stolerman 2002). Mice were also trained with both
fixed and variable inter-trial intervals (ITI) so that α7
−/−
and wild-type animals could be compared for their abilities
in coping with the temporally unpredictable stimuli in the
variable ITI condition. In the later stages of the study, some
parameters were modified to make the training procedure
more similar to that of Young et al. (2004) so as to facilitate
comparisons and to clarify reasons for certain differences in
the results obtained.
Materials and methods
Animals
The animals used were descendants of α7
−/− mice produced
by Orr-Urtreger et al. (1997), bred from heterozygotes
purchased from the Jackson Laboratory, USA (B6.129S7-
Chrna7
tm1 Bay, stock no. 003232). The mice were at
backcross generation N8, the background strain was
C57BL/6, donor strain 129S7 via ABI 2.1 ES cell line;
subsequent breeding was always carried out using hetero-
zygous pairs. Twenty-four male α7
−/− mice and 24 male
wild-type littermates were used in initial training. Genotypes
were determined with the methods used by Stolerman et al.
(2004), and all mice were injected with TROVAN sterile
transponder chips (Mid Fingerprint, Dorset UK) at age
10 weeks. These groups were divided into sub-groups of 12
mice each trained with fixed and variable ITI. One wild-type
mouse was eliminated from the study at an early stage due
to an unresolvable eye infection. Table 1 lists the subsequent
parameter changes that took place as training proceeded.
Food restriction was started at age 11–12 weeks and
behavioural training began a week later. The mice were
kept at 80% of their free-feeding weights as calculated from
a previously obtained growth curve for animals from the
same colony. The animals were weighed daily and fed
accordingly. All animals had access to water while in their
home cages and were individually housed in a room at
21°C and on a 12-h light/dark cycle, with lights coming on
at 0700 hours.
The studies complied with local ethical requirements and
were carried out in accordance with the Animals (Experi-
mental Procedures) Act, 1986.
Apparatus
Sound-insulated and ventilated enclosures containing alumin-
ium operant chambers were used (CENES, Cambridge, UK).
The chambers measured 14 cm across × 12 cm high ×
11–13 cm deep. The back wall of the chamber was curved so
that each nose-poke hole was equidistant from the feeder tray
at the centre of the front of the chamber. There were five nose-
pokeholes1 cm indiameter, 2cmabovethe floor,1.5cm apart
and 1.5 cm deep. Each hole had a green-light-emitting diode at
the end and a photoelectric cell at the opening. The two house
lights were situated 10 cm up the sides of the chamber. An
Acorn computer running Arachnid software (Paul Fray,
Cambridge, UK) under RISC OS collected the data.
Training procedure
The mice were trained for 5 days each week, Monday to
Friday. The training procedure was based on that of Patel
et al. (2006) and was modified from that of Humby et al.
(1999) so as to resemble more closely the procedures in
previous work carried out with the 5-CSRTT in rats
(Bizarro et al. 2004). After the mice were habituated to
handling, training began with four sessions of 5, 10, 15 and
15 min for the mice to habituate to the test chambers. The
house lights were not illuminated at this stage. Before the
next two sessions that were 15 min each in duration, 15–20
food pellets were placed in feeder trays before the start of
each session. This was followed by two sessions of 15- and
20-min duration, respectively, in which food pellets were
presented according to fixed-time schedules of 15 and 30 s.
Nose-poke training then started with four 30-min sessions
of non-spatial training with the stimulus duration set at 60 s
and with an ITI of 2 s. As noted above, subgroups of mice
were trained with ITI of fixed duration, whereas for other
groups, individual ITI varied around the mean value (for
details, see Table 1). In non-spatial training sessions, all
five holes were illuminated simultaneously and a nose-poke
in any hole was reinforced by delivery of a food pellet. For
the first of these sessions, 25 mg food pellets (PJPPP-0020,
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the nose-poke holes to encourage the mice to nose-poke.
For spatial training, the house lights were on at all times
except during time-outs. Each session lasted for 30 min and
there was no limit to the number of trials in a session. A
stimulus was randomly presented in one of the five holes and
a response in the correct hole during the stimulus duration or
thelimited hold (LH) period after thestimulus was reinforced
and followed by a 10-s allowance for the time taken to eat the
food pellet. This was sufficient for mice to consume the food
and return to attending to the task; the next ITI began at the
end of the 10-s allowance for eating. In sessions in which
there was a time-out, this was initiated by a nose-poke
response into an incorrect hole during the stimulus duration
or LH. Premature responses during the ITI in experiment 1
were recorded but had no programmed consequences. Time-
outs involved turning off the lights for 2 s and were followed
immediately by the start of the next ITI.
Experiment 1a: initial acquisition of attentional task
Table 1 describes the stages of training, with criteria for
progression to the next stage being that the mean
percentage of correct responses for each group was greater
than 70% and the mean response latency for each group
was less than the stimulus duration for two consecutive
days. The training parameters were not advanced if the
mice had not been trained the day before. Acquisition was
considered to be complete when the mean percentages of
correct responses was stable for two consecutive weeks.
Experiment 1b: first set of nicotine tests
For testing the effects of nicotine, a reduced number of 15
wild-type and 15 α7
−/− mice were used because it was
known from previous studies that this was a sufficiently
large group size for assessing drug effects (Humby et al.
1999; Hahn and Stolerman 2002). The selected animals
were those that had all been trained at a similar time of day
previously and no other selection criterion was used. Up to
this stage, some mice had been trained with fixed and some
with variable ITI. All selected mice were switched to fixed
ITI mode before drug testing started to reduce the number
of independent variables; all other parameters remained
unchanged. These mice were given saline injections
subcutaneously in the flank after training on each of the
3 days before the first nicotine test day to allow habituation
to the procedure to take place. There were four test days on
consecutive Tuesdays and Fridays. Mice were allocated to a
dosing schedule for injection of saline or 0.001, 0.01 or
0.1 mg/kg nicotine 10 min before the start of each test
session; each mouse was tested once at each dose by the
end of the study and dosing sequences were random. Young
et al. (2004) found that these doses of nicotine significantly
improved the task performance of nicotine-naïve mice.
Experiment 2a: retraining after changing parameters
Seven weeks after the end of experiment 1b, retraining of the
same 30 mice commenced, followed by alterations of
experimental parameters to make them resemble more
closely those used by Young et al. (2004). The changes
entailed reducing the LH from 5 to 2 s, using variable ITI
mode only, and including a 2-s time-out for anticipatory
responses. House lights were extinguished during the time-
outs during which no stimuli were presented, and the
presentation of the next stimulus was delayed by the
duration of the time-out. Although mice originally trained
with fixed ITI mode were at this time trained exclusively in
variable ITI mode, there were no differences in performance
as a function of this variation in training history. Table 1 lists
the details of all the changes in task parameters. The animals
Table 1 Parameters for all experiments
Study Stimulus duration Limited hold Fixed ITI Variable ITI Time-out Anticipatory time-out Sessions to criteria
1a 60 0 2 2 (0.25–3.75) 0 0 7
60 0 4 4 (0.5–7.5) 2 0 2
10 0 4 4 (0.5–7.5) 2 0 2
5 1 4 4 (0.5–7.5) 2 0 4
2 4 4 4 (0.5–7.5) 2 0 7
1 5 4 4 (0.5–7.5) 2 0 28
1b 1 5 4 NA 2 0 NA
2a 1 2 NA 4 (0.5–7.5) 2 2 15
2b 1 2 NA 4 (0.5–7.5) 2 2 NA
Studies 1a and 2a refer to experiments looking at baseline (undrugged) performance at initial and final parameters, whereas studies 1b and 2b
refer to the first and second of the experiments with nicotine. For experiment 1a, where ITI values are shown for both fixed and variable
ITI mode, these refer to settings for different groups of mice. All times stated are in seconds. For variable ITI the mean, smallest and largest
values are shown.
NA Not applicable
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which time performance was relatively stable. One α7
−/−
mouse developed an unusual behavioural phenotype. This
mouse was markedly hyperactive in its home cage, required
approximately twice as much food as the other animals to
maintain its weight and made anticipatory responses at a rate
5–10 times greater than the next most impulsive mouse. No
data from this mouse are presented.
Experiment 2b: second set of nicotine tests
A second experiment with nicotine began immediately after
the end of experiment 2a. The mice were injected with
saline for 3 days before the start of the test sessions so that
they might habituate to the injection procedure. There were
eight test sessions on consecutive Tuesdays and Fridays.
Mice were allocated to a dosing schedule for injection of
saline or 0.001, 0.003, 0.01, 0.03, 0.1, 0.3 or 1 mg/kg
nicotine 10 min before the start of each test session. Each
mouse was tested once at each dose by the end of the study
and dosing sequences were random.
Data analyses
The six behavioural measures selected for analysis were as
follows:
– Accuracy (percentage of correct responses): 100 ×
correct responses/(correct + incorrect responses)
– Omissions (percentage of omission errors): 100 ×
omission errors/stimuli presented
– Latency of correct responses: the mean time between
stimulus onset and a nose-poke in the correct hole
– Latency of incorrect responses: the mean time between
stimulus onset and a nose-poke in any incorrect hole
– Reinforcers earned: equal to the number of correct
responses
– Anticipatory response rate: the mean number of
responses per second during the ITI calculated by
using the following formula: total number of responses
in all ITI of a session/number of trials/ITI length in
seconds.
The accuracy measure was not calculated when the sum
of correct and incorrect responses was 15 or less. For
analysis of variance (ANOVA), percentage data for accu-
racy and omissions were arc-sine transformed, latencies
were log-transformed and anticipatory response data were
subject to square root transformation, as in previous studies
(Hahn et al. 2002, 2003a; Patel et al. 2006). For post hoc
tests, the Bonferroni correction for multiple comparisons
was applied to t tests. Graphs show untransformed data.
Results for each measure were analysed by ANOVA for
repeated measures using Unistat 5.0 for Excel, three-factor
ANOVA was used to examine data from experiment 1a and
two-factor ANOVA was used for experiments 1b, 2a and
2b. Further details of the factors are given below, at relevant
places in the Results section.
Drugs
Nicotine hydrogen tartrate (Sigma, UK) was dissolved in
isotonic saline with pH adjusted to 7 with NaOH solution.
All injections were given s.c. in the flank in a volume of
1 ml/100 g and all doses were those of the nicotine base.
Results
Experiment 1a: initial acquisition of attentional task
There were no significant differences between any of the
groups with respect to any parameter of performance at the
first stage of training with the stimulus duration set at 60 s
and the ITI at 2 s. Figure 1a) shows the similarity in the
changes in accuracy for α7
−/− and wild-type mice over
these first seven sessions. It can be seen that the data show
signs that the mice began to learn the task from the very
earliest stage of training. Results for other variables are not
shown because they were similarly negative with respect to
genotype.
Fig. 1 Experiment 1a: accuracy of 5-CSRTT performance for wild-
type (●) and α7
−/− mice (○) during the first seven sessions of
training in the 5-CSRTT. Results show main effects of genotype and
training day as means±SEM for groups of 23 mice. Subgroups of mice
with each genotype were trained with fixed and variable inter-trial
intervals without effect on performance (data not shown)
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sively greater demands made upon the animals’ ability by
altering task parameters, such as reducing the stimulus
duration (Table 1). Differences between the genotypes then
emerged, including changes in accuracy, response latencies
and anticipatory responding. The data for intermediate
stages of training are not shown for brevity; they largely
replicated the observations made when the final set of task
parameters was in operation. The performance of the
animals was relatively stable during the last 10 days of
training under the final parameters and these data were
selected for analysis and are presented next.
Data for the final 10 days of training were examined by
three-factor analysis of variance, the factors being geno-
type, ITI mode, and days. This analysis yielded main
effects of genotype on accuracy [F(1, 42)=8.67, p<0.01],
reinforcers earned [F(1, 42)=12.3, p<0.01], anticipatory
response rate [F(1, 42)=4.50, p<0.05] and arguably, on
correct response latency [F(1, 42)=3.96, p=0.053].
Figure 2a shows that α7
−/− mice were much less accurate
Fig. 2 Experiment 1a: main
effects of genotype and day of
training on performance of wild-
type (●) and α7
−/− mice (○)
during the last 10 days before
drug testing began (n=23). Sub-
groups of mice of each genotype
were trained in fixed (F) and
variable (V) inter-trial interval
modes; inset bar graphs illus-
trate the significant main effects
of this variable. All data shown
are means±SEM (n=23)
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response, earned fewer reinforcers and responded more
frequently during the ITI. Neither the three-way (group ×
ITI mode × day) nor any two-way interaction was
significant for any of the parameters measured. For changes
across the ten successive days of training, omission errors
[F(9, 378)=4.99, p<0.0001], reinforcers earned [F(9, 378)=
3.28, p<0.001] and anticipatory response rate [F(9, 378)=
2.11, p<0.05] showed significant effects. Most of these
effects did not show consistent patterns over days (Fig. 2)
and are not considered further.
For ITI mode, there were significant main effects for two
variables, correct response latency [F(1, 42)=9.27, p<0.01]
and reinforcers earned [F(1, 42)=6.25, p<0.02], with those
mice trained on variable ITI mode being slower to make
correct responses and obtaining fewer reinforcers. The inset
bar graphs in Fig. 2c and e illustrate the significant main
effects of ITI mode.
Experiment 1b: first set of nicotine tests
Data were examined with two-factor analysis of variance,
the factors being genotype and drug (nicotine) dose. There
were no significant effects of nicotine (0.001–0.1 mg/kg)
upon any measure of performance [largest F(3, 78)=2.32,
p=0.082, for correct response latency]. The main effect of
genotype was significant for accuracy [F(1, 26)=4.42,
p<0.05] and reinforcers earned [F(1, 26)=6.55, p<0.02].
Table 2 shows means±SEM. for both wild-type and α7
−/−
mice, for each attentional parameter, over the 30-min
sessions. As in experiment 1a, α7
−/− mice were less
accurate than wild-types and earned fewer reinforcers.
Genotypes did not differ significantly for other variables,
although inspection of Table 2 reveals trends for omission
errors, correct response latencies and anticipatory response
rate that were in the same direction as the effects seen in
experiment 1a. There were no significant interactions
between genotype and nicotine.
Experiment 2a: retraining after changing parameters
After the parameter changes listed in Table 1, animals were
retrained on the task for several weeks and the relatively
stable performance during the last ten sessions of training
before tests with nicotine was selected for analysis. Data
were examined by means of two-factor analysis of variance,
the factors being genotype and day of training. The analysis
yielded significant effects of genotype on omission errors
[F(1, 29)=20.4, p<0.001] and reinforcers earned [F(1, 29)=
19.7, p<0.001], but not on accuracy, correct or incorrect
response latency or anticipatory response rate [maximum
F(1, 29)=1.73]. The α7
−/− mice omitted responses to a
greater percentage of stimuli and earned fewer reinforcers
than wild-types; these effects were clearly manifested
during each of the 10 days of training (Fig. 3b,e).
There were also small but significant differences
between correct response latencies and anticipatory
responding over days. Anticipatory responding occurred at
a lower rate in the later stages of training [F(9, 241)=7.07,
p<0.0001]; the latency of correct responses also varied over
days, but no clear pattern was evident [F(9, 241)=2.12,
p<0.05]. The day of training had no effect on any other
parameter. There were no significant genotype × day
interactions.
Table 2 Mean±SEM effects of nicotine (0.001–0.1 mg/kg) on attentional parameters in the 5-CSRTT in α7 knockout (KO) mice and their wild-
type (WT) littermates
Attentional parameters
Nicotine (mg/kg) Accuracy (percent correct) Omission errors (percent omissions) Correct response latency (s)
WT KO WT KO WT KO
0.0 88.9±1.7 84.7±2.3 27.4±2.8 30.5±1.8 0.79±0.03 0.85±0.03
0.001 89.7±1.3 84.2±2.7 25.7±2.2 30.3±1.7 0.78±0.02 0.84±0.04
0.01 88.0±2.1 81.7±2.5 27.4±2.3 31.5±2.4 0.80±0.02 0.82±0.02
0.10 88.8±2.0 83.2±1.8 26.1±2.5 29.6±2.4 0.81±0.02 0.89±0.03
Incorrect response latency (s) Reinforcers earned (30 min) Anticipatory responses/s
WT KO WT KO WT KO
0.0 2.27±0.19 2.25±0.22 89.0±2.9 82.7±2.5 0.042±0.010 0.052±0.010
0.001 2.05±0.24 2.45±0.11 90.8±2.5 82.9±3.0 0.038±0.008 0.059±0.010
0.01 2.32±0.16 2.16±0.14 88.1±2.0 80.3±2.7 0.045±0.013 0.061±0.013
0.10 2.32±0.20 2.41±0.15 90.1±2.9 82.6±2.3 0.041±0.011 0.063±0.013
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These data were examined by two-factor analysis of
variance, the factors being genotype and drug (dose of
nicotine). There were no effects of genotype [F(1, 27)=
2.79] or drug [F(7, 179)=1.44] on the percentage of correct
responses; nor was there a significant group × genotype
interaction [F(7, 179)=0.97]. For omission errors there was
a significant effect of genotype [F(1, 27)= 16.7, p<0.0001]
and of drug [F(7, 189)=82.4, p<0.0001] and additionally, a
drug × group interaction was observed [F(7, 189)=6.40,
p<0.0001]. From Fig. 4b it can be seen that the effect of
genotype arises from the slightly larger overall number of
omission errors made by the α7
−/− mice. In view of the
significant interaction, this difference was examined sepa-
rately at each dose of nicotine by means of t tests with
Bonferroni corrections for multiple comparisons. These
analyses yielded significant differences between the geno-
types at nicotine doses of 0.003, 0.01, 0.1 and 1.0 mg/kg; in
all cases the percentage of omission errors was greater in
Fig. 3 Experiment 2a: main
effects of genotype and training
day on performance of wild-type
(●) and α7
−/− mice (○) after
reduction of limited hold from 5
to 2 s and introduction of 2-s
time-out for anticipatory
responding (all mice trained in
variable ITI mode). Results
shown are for the last 10 days of
training with the preceding al-
tered parameters before the sec-
ond set of tests with nicotine.
Data shown are means±SEM
(n=14–15)
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−/− than in the wild-type animals. Nicotine increased
omission errors markedly at the largest dose tested, and this
effect was greater in the α7
−/− than in the wild-type mice.
There was no main effect of genotype on correct latency
[F(1, 27)=1.47]. The main effect of drug on this measure
was significant [F(7, 183)=22.4, p<0.0001] and this
appeared to be entirely due to an increase in latency at the
largest dose of nicotine (Fig. 4c). The interaction was not
significant [F(7, 183)=1.63]. There was also a significant
effect of drug on incorrect latencies [F(7, 166)=2.23,
p<0.05), although its origin is not obvious from Fig. 4d
and there was no dose–response relationship.
With respect to reinforcers earned, there were significant
effects of genotype [F(1, 27)=20.7, p<0.0001], drug [F(7,
189)=82.0, p<0.0001] and a group × drug interaction [F(7,
189)= 8.71, p<0.0001]. The overall number of reinforcers
earned was slightly greater in wild-type than in α7
−/− mice,
and Fig. 4e shows that this difference was significant at four
Fig. 4 Experiment 2b: main
effects of genotype and nicotine
dose on performance of wild-
type (●) and α7
−/− mice (○)
after reduction of limited hold
from 5 to 2 s and introduction of
2-s time-out for anticipatory
responding (all mice trained in
variable ITI mode). Data shown
are means±SEM (n=14–15).
Asterisks represent differences
between genotypes at each dose
of nicotine determined by t tests
with Bonferroni correction;
*p<0.05, **p<0.01)
Psychopharmacology (2006) 189:211–223 219of the eight dose levels of nicotine that were tested. Nicotine
itself decreased the number of reinforcers at the largest dose
tested and this effect was greater in α7
−/− than in wild-type
mice. Finally, there was a significant effect of nicotine [F(7,
189)=15.8, p<0.0001] but not genotype [F(1, 27)=1.10] on
anticipatory responding. The effect of drug may be attributed
to a decrease in the rate of responding at the 1.0 mg/kg dose
of nicotine (Fig. 4f). A significant drug × genotype
interaction was seen [F(7, 189)=2.39, p<0.05], but post hoc
tests did not identify a significant difference between the
genotypes at any dose level of nicotine.
Discussion
The five-choice serial reaction time task revealed impair-
ments in the performance of the α7 nicotinic receptor
knockout mice on a variety of measures, thus supporting
the view that these receptors play a role in attentional
performance. Analysis through variation in task parameters
suggested that the primary deficit was an increase in
omission errors; a general slowing in performance would
have been reflected in corresponding increases in response
latencies and decreases in anticipatory responding. Thus,
the α7
−/− mice failed to detect significantly more stimuli
than the wild-types, but when they did detect a stimulus
they responded to it quickly and correctly. These findings
confirm and extend the key observations of Young et al.
(2004) and support the emerging consensus that although
α7
−/− mice show deficits in the performance of several
cognitive tasks, the differences from controls are modest
and are manifest only with specific tasks used under
precisely defined conditions (Paylor et al. 1998; Wehner
et al. 2004; Fernandes et al. 2005). We now discuss in detail
some differences between our results and those of Young et
al. (2004) and indicate how they can be reconciled by
considering parametric variations in the procedures used.
In the present study, α7
−/− mice did not differ from wild
types until the later stages of training, where the more
stringent task parameters placed greater demands upon their
cognitive ability (Fig. 2). These differences in the baseline
(undrugged) performance of the α7
−/− mice and wild-type
mice were largely replicated in our first study on the
response to nicotine (Fig. 3). The impaired accuracy and
increased response latency suggested an attentional impair-
ment, whereas the increase in anticipatory responding
suggested greater impulsivity. Keller et al. (2005) also
found that the amount of anticipatory responding was
increased in α7
−/− mice, although they used a different
behavioural procedure.
There is often an inverse relationship between accuracy
and impulsivity in the 5-CSRTT, and from a comparison of
inbred mouse strains it was argued that a decrease in
accuracy could be secondary to increased impulsivity (Patel
et al. 2006). The observed change in impulsivity may have
contributed to the decrease in accuracy in experiment 1a,
which should, therefore, be interpreted cautiously. We did
not observe slow acquisition of task performance like that
seen by Young et al. (2004); a primary effect on
anticipatory responding may have contributed to their
finding, too, rather than a deficit in learning ability. This
interpretation is supported by the absence of impairments in
α7
−/− mice in a variety of other learning tasks (Paylor et al.
1998) and is especially likely with the definition of
accuracy used by Young et al. (2004), which included the
number of anticipatory responses in the denominator for
calculation of the proportion of correct responses.
During experiment 1a we did not observe any difference
between α7
−/− and wild-type mice with respect to omission
errors. Interestingly, Young et al. (2004) reported an
increase in omission errors in the α7
−/− mice. The
difference in durations of the limited holds (LH) used in
the two studies may explain this apparent disagreement.
The LH, the period in which responses are recorded as
being correct or incorrect following stimulus termination,
was 2 s in Young et al. (2004) and 5 s in the final stage of
experiment 1a. When, with a long LH, a stimulus is not
detected, ‘impulsive’ responses in the period of the LH are
more likely to be recorded as incorrect than as correct
responses, as there are four times more incorrect response
options than there are correct options. The increased
impulsivity observed in α7
−/− mice may, therefore, have
contributed to the observed reduction in accuracy.
At the same time, an increase in omission errors such as
that reported by Young et al. (2004) may have been
masked, as training with a long limited hold gives the
animals more time to make an impulsive response. The
trend (p<0.06) towards longer correct response latencies in
α7
−/− mice in experiment 1a might also be explained by
late ‘correct’ impulsive responses rather than slower
reactions. Both groups had short response latencies and
the differences between them were eliminated when
impulsive responses were punished and the LH was
reduced in experiment 2a. Additional and more detailed
data on the temporal and spatial patterning of errors and
systematic studies of the effects of punishment and of
varying LH is needed to establish the validity of this
interpretation.
In an attempt to understand the origin of the differences
between the present results and those of Young et al.
(2004), we retrained the mice with the LH reduced from 5
to 2 s, used only variable ITI and introduced a 2-s time-out
for anticipatory responses; these task parameters resembled
closely those of Young et al. (2004). In experiment 2a,
carried out under these altered conditions, there was a clear
increase in omission errors in the α7
−/− mice. In contrast,
220 Psychopharmacology (2006) 189:211–223the percentage of correct responses was similar in wild-type
and α7
−/− animals and the previously observed differences
in the latencies of correct responses and in anticipatory
response rates were no longer seen. This pattern of deficits
in α7
−/− mice was indistinguishable from that observed by
Young et al. (2004).
The absence of a difference in anticipatory responding
between genotypes may have been associated with the
reduction in its rate as a consequence of the time-out
contingency in experiment 2a; the use of variable ITI in the
retraining phase may also have been important because the
initial difference between the wild-type and α7
−/− mice in
anticipatory responding was greater in animals trained with
fixed interval than with variable interval (Fig. 2). This
observation might reflect impaired utilisation of temporally
predictable stimuli in the α7
−/− mice, rather than differ-
ences in impulsivity per se. Nevertheless, caution is needed
because the altered performance after parametric changes
may also have been associated with the longer training and
greater age of the animals at this stage.
In experiment 1b, the absence of any significant effect of
nicotine even in wild-type mice could have been attributed
to the parameters of the schedule maintaining the behav-
iour. Nevertheless, the doses of nicotine used were within
the range reported to improve accuracy and reduce
omission errors in mice (Young et al. 2004). It, therefore,
seemed possible that a nicotine effect would emerge when
the training parameters were adjusted to resemble those
used by Young et al. (2004). However, this was not the case
and in experiment 2b; no dose of nicotine improved
performance on any variable. The largest dose of nicotine
impaired performance; omission errors and the latencies of
correct responses increased, whereas reinforcers earned and
anticipatory responses decreased (Fig. 4f). This pattern of
results can be attributed to a general deficit in operant
response rates produced by the very large (1 mg/kg) dose of
nicotine. The lack of change in accuracy is compatible with
explanations in terms of motor impairment rather than an
attentional deficit. The data in Fig. 4a indicate that these
effects of nicotine were also present in the α7
−/− mice and,
in some cases, their magnitude was increased (e.g. omission
errors). The reason for this unexpected observation is
unclear; it may represent a little more than a minor
enhancement at certain doses of nicotine of the significant
main effect of genotype on omission errors.
Why was there no improvement in attentional perfor-
mance by any dose of nicotine? A ceiling effect associated
with the very high baseline accuracy offers only a partial
explanation because the baseline rate of omission errors
was high (30%), but there was still no nicotine-induced
improvement on either measure. Prior exposure to nicotine
might be relevant, but Young et al. (2004) obtained positive
effects of nicotine at 0.003 and 0.3 mg/kg in mice
previously exposed to the drug and in rats, nicotine-induced
attentional enhancement did not show tolerance during
6 weeks of daily exposure to the drug (Hahn and Stolerman
2002). The parameters for training and testing during
experiment 2b were also very similar to those used by
Young et al. (2004). On the basis of the available
information it appears that nicotine-induced improvement
of performance in wild-type mice with a C57BL/6
background is not a robust phenomenon.
This aspect of the study contrasts with the good
agreement of the present results with those of Young et al.
(2004) with respect to the performance of α7
−/− and wild-
type mice in experiments 1a and 2a. Comparisons between
C57BL/6 and DBA/2 mice in the 5-CSRTT have also been
carried out in two different laboratories, and there was
excellent agreement between the results; in each case, the
DBA/2 mice were the poorer performers, exhibiting
increased impulsivity and lower accuracy (Greco et al.
2005; Patel et al. 2006). DBA/2 mice had reduced levels of
α7e x p r e s s i o na n di m p a i r e ds e n s o r yg a t i n gt h a tw a s
corrected by α7 agonists (Stevens et al. 1998).
The present work did not investigate the mechanisms
underlying the impaired performance of α7
−/− mice, but
some suggestions can be made. Investigations of brain
areas important for attentional performance using localised
lesions and drug administration have demonstrated the
involvement of the medial prefrontal cortex and D1
dopamine receptor activation within this area (Muir et al.
1996; Granon et al. 2000; Hahn et al. 2003b). Dopamine
utilisation in the frontal cortex also appears to be reduced in
individual rats that perform badly in the task (Puumala and
Sirvio 1998), whereas the α7 agonist GTS-21 elevated
dopamine and noradrenaline concentrations in the fronto-
parietal cortex, which is implicated in attentional function
(Summers et al. 1997); it is possible that a reduction or lack
of α7 receptors might lead to a deficit in dopamine levels in
the fronto-parietal cortex, although changes in neurotrans-
mitter systems other than dopamine may also contribute.
It can be suggested, speculatively, that the α7
−/− mouse
may have some value as a model for very specific aspects
of the cognitive dysfunctions in schizophrenia. Diminished
frontal dopamine has been hypothesised to be important in
schizophrenia (Davids et al. 2003; Laruelle et al. 2003), and
post-mortem studies have shown diminished numbers of α7
receptors in brains of schizophrenics. The α7
−/− mouse has
not been tested for an auditory sensory gating deficit, the
endophenotype of schizophrenia in which the α7 nicotinic
receptor has been strongly implicated (Freedman et al.
2002) and which may offer a cognitive explanation for the
attentional deficits observed.
In conclusion, this study confirms that α7
−/− mice exhibit a
weakened ability to detect visual stimuli in a test of sustained
attention, suggesting that the presence of α7 receptors is
Psychopharmacology (2006) 189:211–223 221necessary for normal task performance. Manipulating task
parameters can alter the apparent nature of the deficit,
suggesting a need to compare different strains of mice under
more than one set of conditions to characterise them
adequately. While this observation encourages further inves-
tigation of the value of α7 receptor agonists in neuropsychi-
atric states such as dementia (Kitagawa et al. 2003)a n d
schizophrenia (Martin et al. 2004), the lack of effect with
nicotine in the present experiments is a major concern.
Identification of a protocol for assessing attention-enhancing
effects of nicotine in mice may require further modifications
of protocols or the use of different strains of animal.
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